Cargando…
Use of Micro Bioreactor systems to streamline cell line evaluation and upstream process development for monoclonal antibody production
Autores principales: | Warr, Steve R C, Patel, Jai, Ho, Rongzan, Newell, Katy V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284950/ https://www.ncbi.nlm.nih.gov/pubmed/22373478 http://dx.doi.org/10.1186/1753-6561-5-S8-P14 |
Ejemplares similares
-
Streamlined process development using the Micro24 Bioreactor system
por: Warr, Steve RC, et al.
Publicado: (2013) -
Single use bioreactors for the clinical production of monoclonal antibodies – a study to analyze the performance of a CHO cell line and the quality of the produced monoclonal antibody
por: Diekmann, Sonja, et al.
Publicado: (2011) -
Development and fine-tuning of a scale down model for process characterization studies of a monoclonal antibody upstream production process
por: Harmsen, Mareike, et al.
Publicado: (2011) -
Study of a recombinant CHO cell line producing a monoclonal antibody by ATF or TFF external filter perfusion in a WAVE Bioreactor™
por: Clincke, Marie-Françoise, et al.
Publicado: (2011) -
Cell line selection using the Duetz Microflask system
por: Warr, Steve R C, et al.
Publicado: (2011)